MENU
+Compare
LTRN
Stock ticker: NASDAQ
AS OF
Jan 8, 04:59 PM (EDT)
Price
$3.93
Change
-$0.19 (-4.61%)
Capitalization
44.43M

LTRN Lantern Pharma Forecast, Technical & Fundamental Analysis

a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data

Industry Biotechnology
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LTRN with price predictions
Jan 07, 2025

LTRN's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for LTRN turned positive on January 03, 2025. Looking at past instances where LTRN's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where LTRN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on LTRN as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

LTRN moved above its 50-day moving average on January 03, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LTRN crossed bullishly above the 50-day moving average on January 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where LTRN advanced for three days, in of 215 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LTRN moved out of overbought territory on December 05, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LTRN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LTRN broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.671) is normal, around the industry mean (15.474). P/E Ratio (0.000) is within average values for comparable stocks, (87.717). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.764). LTRN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (271.147).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LTRN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LTRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LTRN is expected to report earnings to rise 40.48% to -58 cents per share on March 06

Lantern Pharma LTRN Stock Earnings Reports
Q4'24
Est.
$-0.59
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.08
Q4'23
Beat
by $0.01
The last earnings report on November 07 showed earnings per share of -41 cents, beating the estimate of -56 cents. With 31.90K shares outstanding, the current market capitalization sits at 44.43M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
21
Web
https://www.lanternpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME33.370.55
+1.68%
GameStop Corp
SPY588.63-6.73
-1.13%
SPDR® S&P 500® ETF Trust
AAPL242.21-2.79
-1.14%
Apple
TSLA394.36-16.69
-4.06%
Tesla
BTC.X96922.700000-5155.383000
-5.05%
Bitcoin cryptocurrency

LTRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with NAUT. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then NAUT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-1.67%
NAUT - LTRN
33%
Loosely correlated
-1.15%
INZY - LTRN
30%
Poorly correlated
-2.42%
MNMD - LTRN
30%
Poorly correlated
+5.46%
APGE - LTRN
27%
Poorly correlated
+2.65%
GBIO - LTRN
26%
Poorly correlated
-8.77%
More